Oryzon Genomics S.A. announced a private placement of 818,367 shares at an issue price of 2.2 per share for a gross proceeds of 800,407 on December 20, 2022.
Market Closed -
Other stock markets
|
After market 03:59:48 pm | |||
1.952 EUR | +0.10% | 1.952 | 0.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.39% | 121M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- ORY Stock
- News Oryzon Genomics S.A.
- Oryzon Genomics S.A. announced that it has received €1.800407 million in funding